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Abstract
In nature, many microorganisms form specialized complex, multicellular, surface-attached communities called biofilms.
These communities play critical roles in microbial pathogenesis. The fungal pathogen Candida albicans is associated with
catheter-based infections due to its ability to establish biofilms. The transcription factor Bcr1 is a master regulator of C.
albicans biofilm development, although the full extent of its regulation remains unknown. Here, we report that Bcr1 is a
phosphoprotein that physically interacts with the NDR kinase Cbk1 and undergoes Cbk1-dependent phosphorylation.
Mutating the two putative Cbk1 phosphoacceptor residues in Bcr1 to alanine markedly impaired Bcr1 function during
biofilm formation and virulence in a mouse model of disseminated candidiasis. Cells lacking Cbk1, or any of its upstream
activators, also had reduced biofilm development. Notably, mutating the two putative Cbk1 phosphoacceptor residues in
Bcr1 to glutamate in cbk1D cells upregulated the transcription of Bcr1-dependent genes and partially rescued the biofilm
defects of a cbk1D strain. Therefore, our data uncovered a novel role of the NDR/LATS kinase Cbk1 in the regulation of
biofilm development through the control of Bcr1.
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Introduction
Biofilms are surface-attached microbial communities embedded
in an extracellular matrix. Cells in a biofilm exhibit phenotypic
properties different from those of their planktonic counterparts,
including an increased resistance to the host immune system and
to antimicrobial agents [1–3]. Several tissues, as genitourinary or
oral epithelia, and biomedical devices can serve as substrates for
biofilm development. In this context, biofilm formation is a key
feature in microbial pathogenesis.
Among the pathogenic fungi, C. albicans is one of the organisms
most commonly associated with implant-related infections [2,4,5].
C. albicans is a polymorphic fungus that can change between three
different forms: yeast, pseudohyphae and hyphae. Morphogenetic
transitions are critical for the acquisition of proper biofilm
architecture: initially, a basal layer of cells is formed when yeast
cells attach to a surface followed by cell division and proliferation.
In a second phase, cells differentiate into hyphal and pseudohy-
phal forms and produce extracellular material; the development of
these forms and the increase in extracellular matrix deposition
would finally arise in a dense and mature biofilm structure. Genes
required for hyphal morphogenesis, cell wall remodeling, amino
acid and lipid metabolism and glycolytic processes have been
involved in the progression of biofilm formation in C. albicans (for a
review, see [6]). Notably, biofilm development requires the
activation of specific transcription programs different from those
of free-living planktonic cells [7]. Tec1, a hypha-specific gene
regulator; Bcr1, required for the expression of different cell wall
proteins and Zap1, which governs matrix production, are
examples of C. albicans biofilm transcriptional regulators [8–11].
In particular, Bcr1 has been shown to regulate the expression of a
subset of genes encoding cell wall-anchored proteins including
members of the agglutinin-like protein family, such as Als1 and
Als3, and the hyphal wall protein Hwp1 [9,12]. Deletion of BCR1
results in defective biofilm formation in vivo and in vitro because of
altered cell-to-cell interactions mediated by Als1, Als3 and Hwp1
[9].
The RAM signaling network is a conserved pathway that
controls cell separation, polarized growth and cell integrity in yeast
[13–17]. In Saccharomyces cerevisiae, the central core of the pathway
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consists of the Cbk1 kinase, a member of the NDR/LATS kinase
family, its binding partner Mob2, the scaffolding protein Tao3,
and the Ste20-like kinase Kic1. The activity of Cbk1, the main
effector of the RAM pathway, is regulated by phosphorylation in a
Kic1- and Tao3-dependent manner [18]. While Cbk1 polarity
targets still remain largely unknown, the control of cell separation
depends on the regulation of the transcription factor Ace2
[14,19,20]. It has been shown that Cbk1 phosphorylates Ace2 at
the end of mitosis, triggering its accumulation at the daughter cell
nucleus and leading to the asymmetric expression of genes
involved in septum degradation [20]. Orthologues of the RAM
pathway have been recently reported in C. albicans [16,17]. As in S.
cerevisiae, RAM mutants exhibited cell separation defects and loss of
cell polarity. In addition, the phenotypic analysis of a library of
protein kinase mutant strains has shown that a cbk1D mutant is
defective in biofilm formation although the function of Cbk1 in
this process has not been further characterized [21].
The protein Cbk1 is a basophilic S/T protein kinase that
exhibits a high specificity for motifs with His at the 25 position
and the basic amino acids Lys or Arg at either the 23 or 22
positions [20]. This motif also seems to be the substrate of other
kinases of the NDR/LATS family, such as the Drosophila
melanogaster Warts/Lats and human LATS1 [22–24]. A search
for this motif in the C. albicans proteome revealed that 0.6% of the
proteins contain two or more putative Cbk1 consensus sites.
Consistent with the conserved role of NDR kinases in the control
of transcriptional activity, transcription factors were enriched
among the putative targets, including several involved in biofilm
development such Ace2 (3 sites), Bcr1 (2 sites), Nrg1 (3 sites) and
Zap1 (3 sites) [25,8,10,26]. Therefore, this observation suggested
that the NDR/LATS kinase Cbk1 could regulate biofilm
formation by acting on transcription factors that trigger the
biofilm developmental program in C. albicans. In the present study,
we focus on the role of Cbk1 in the control of Bcr1, a master
regulator of biofilm formation [27]. We and others previously
established that Cbk1 is essential for hyphal development [16,17].
Here, we demonstrate that Cbk1 is also a regulator of biofilm
formation through phosphorylation of Bcr1 at T191 and S566
residues. Thus, the Cbk1 kinase is emerging as a pivotal regulator
of several developmental programs that are essential for the
biology and pathogenesis of C. albicans.
Results
RAM mutants show severe defects in biofilm formation in
vitro
Although a role for Cbk1 in biofilm formation has been
reported [21], no quantification of biofilm-formation defect of cells
lacking Cbk1 has been published. To characterize the severity of
the phenotype of cbk1D cells in biofilm formation, cells were grown
under biofilm inducing conditions using a microfermentor model
[7] and compared to wild-type and bcr1D reference strains. In the
wild-type strain, cells thoroughly colonized the Thermanox plastic
slide producing a thick and cottony biofilm. In contrast, cbk1D
mutant developed very poor haze-like biofilm structures in which
colonization of the plastic slides and biomass production were
dramatically reduced, similar to that of bcr1D cells (Figure 1A and
1B). The function of Cbk1 in biofilm formation depends on the
RAM pathway since mutants defective in different components of
the RAM network (kic1D, tao3D, and mob2D) phenocopied cbk1D
cells. The same strains were tested using a biofilm formation model
on silicon squares [8] to perform confocal scanning laser
microscopy (CSLM). As expected, wild-type reference strain
produced a complex biofilm structure of interconnected yeasts,
pseudohyphae and hyphae whereas bcr1D mutant developed a
rudimentary biofilm that included yeast cells with few pseudo-
phyphae and hyphae. However, RAM mutants produced biofilms
comprised exclusively of isolated clumps of yeast cells (Figure 1D).
Thus, our data indicates that the absence of RAM signaling causes
a severe defect in biofilm development.
The structural defects of RAM mutant biofilms could be due to
their inability to develop hyphae [16,17]. Nevertheless, in contrast
to other mutants defective in hyphal formation such as cph1D efg1D
[7], RAM mutants were even unable to form a compact primary
layer of yeast cells on the slides, which might suggest a defect in
adhesion. The RAM pathway regulates the activity of the
transcription factor Ace2, which controls the expression of cell
wall genes [19,28,15]. As shown in Figure 1, no significant
differences were found in biomass production in microfermentor
experiments between ace2D and RAM mutants. It has been
reported that the ace2D mutant has a moderate defect in
adherence to plastic surfaces [25]. In order to assess whether the
defects in attachment to plastic or silicone surfaces of the RAM
mutants were due to an Ace2 misregulation, the adherence of
RAM and ace2D mutants was quantified and compared to wild-
type and bcr1D reference strains (Figure 1C; see Materials and
Methods). Whereas ace2D cells showed a 50% reduction in
adherence compared to the wild-type control, the defect exhibited
by RAM mutants was more dramatic, with a 90% decrease in the
number of adherent cells similar to that of bcr1D cells. Therefore,
these results indicate that adherence impairments of RAM
mutants could not be solely due to defects in Ace2 transcriptional
regulation.
Bcr1 is a phosphoprotein that interacts with Cbk1 in vivo
The above results suggested that the Cbk1/Mob2 complex,
the main effector of the RAM pathway, might target key
regulators of biofilm formation other than Ace2. The transcrip-
tion factor Bcr1 controls the expression of cell-surface genes and
it is required for biofilm formation in vitro and in vivo [8,9].
Interestingly, Bcr1 contains two putative Cbk1 consensus
phosphorylation sites at T191 and S556, one of which is located
at the end of the first Zn finger (Figure 2A), suggesting that it
could be regulated by the RAM pathway. Western blot analysis
of cells expressing a functional Bcr1 tagged allele (BCR1-HA)
grown at 37uC in Spider medium showed that Bcr1 is a
Author Summary
C. albicans infections frequently involve the formation of
biofilms on implanted devices such as indwelling cathe-
ters. These complex communities of surface-associated
fungal cells embedded in a matrix of extracellular
polysaccharides protect C. albicans from host defences
and antifungal agents. In recent years, several genes
involved in the development of biofilms of C. albicans have
been identified. These studies have uncovered complex
regulatory networks that control the activity of several
transcription factors during different steps of biofilm
development. Bcr1 is a transcription factor that plays a
major role in this process and yet, its regulation has not
been studied extensively. Here, we show that Bcr1
function in biofilm formation and virulence requires
phosphorylation of threonine 191 and serine 556 by the
NDR/LATS kinase Cbk1. Moreover, given that Cbk1 is also
required for the onset and maintenance of hyphal growth,
our study highlights this kinase as a pivotal regulator of
several developmental programs that are essential for the
biology and pathogenesis of C. albicans.
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Figure 1. The RAM pathway is required for biofilm formation in vitro. (A) The wild-type (CEC369) and bcr1D (JC1081) reference strains, cbk1D
(JC1080), mob2D (JC525), tao3D (JC848), kic1D (JC798) and ace2D (JC343) mutants were incubated during 40 hours in biofilm-inducing conditions on
Thermanox plastic slides in microfermentors. (B) Determination of biofilm dry mass collected from microfermentors shown in (A). Average results of
two independent experiments done in duplicate are shown. Error bars represent the standard deviation of the data throughout the paper, unless
otherwise indicated. (C) Adherence to plastic slides of WT, bcr1D, RAM mutants and ace2D, as detailed in Materials and Methods. The results shown
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phosphoprotein (Figures 2B). To analyze the phosphorylation
pattern in greater detail, we used two-dimensional gel electro-
phoresis followed by Western blotting (2D-WB). On the basis of
this approach, Bcr1 showed a complex phosphorylation pattern
with multiple spots along the pH gradient (Figure 2C). Treat-
ment with l-phosphatase produced a single dot that ran at the
middle of the pH gradient. When cell extracts from the cbk1D
strain were analyzed by 2D-WB, the relative abundance of the
different Bcr1 isoforms was shifted to intermediate spots,
corresponding to less phosphorylated isoforms (Figure 2C). Thus,
the phosphorylation state of Bcr1 appears to be Cbk1-depen-
dent.
To obtain further evidence that Bcr1 interacts with Cbk1 in vivo,
we performed co-immunoprecipitation experiments from extracts
of cells expressing Cbk1-myc and Bcr1-HA from their native
promoters. This approach clearly showed an in vivo interaction
between these two proteins (Figure 2D). Taken together, these
data suggest that Bcr1 could be a direct target of the NDR/LATS
kinase Cbk1 in vivo.
The Cbk1 consensus phosphorylation sites in Bcr1 are
required for adherence and biofilm formation in vitro
To determine whether the putative Cbk1 phosphorylation sites
are important for Bcr1 function in vivo, we mutated them and
analyzed the effect of these mutations in biofilm formation. We
constructed phosphomimetic and phosphodefective versions of
Bcr1 by replacing the T191 and S556 putative Cbk1 phosphoac-
ceptor residues with Glu or Ala, respectively. The mutant alleles
were used to replace the wild-type copy of a heterozygous BCR1/
bcr1D strain, resulting in strains containing the mutant alleles
under the control of the native promoter as the sole source of Bcr1
in the cell. The phenotypes of these bcr1 mutants were compared
to those of the BCR1 heterozygous and bcr1D null mutant strains.
It has been reported that bcr1D mutants exhibit severe defects in
adherence and biofilm formation [8,9]. We did not observe any
significant difference in adherence between the bcr1T191E, bcr1S556E
and bcr1T191E/S556E (referred to as bcr1EE) mutant strains and the
BCR1/bcr1D reference strain (Figure 3A). Furthermore, biofilm
biomass production by the three phosphomimetic mutants was
similar to that of the reference wild-type control and no significant
statistical differences were found between them (bcr1T191E,
p = 0.0826; bcr1S556E, p = 0.7472 and bcr1T191E/S556E, p = 0.1282)
(Figure 3B). In addition, CSLM imaging revealed that biofilm
architecture of these mutants was similar to that of the wild type
(Figure 3C). In contrast, all strains carrying mutations to alanine
(bcr1T191A, bcr1S556A and bcr1T191A/S556A referred to as bcr1AA)
showed a significant decrease in the number of adherent cells and
in biofilm development. These defects were more severe in the
bcr1T191A and bcr1AA mutants, which showed values closer to the
bcr1D mutant, than in the bcr1S556A mutant. Finally, CSLM
imaging revealed that the biofilm structure of alanine mutants was
very rudimentary and mainly composed of yeast cells, with few
pseudohyphae and hyphae. However, the bcr1S556A mutant
exhibited a more organized and compact primary cell layer than
that formed by the bcr1T191A and bcr1AA strains, suggesting a
different contribution of the two phosphorylation sites to Bcr1
regulation. Thus, these data indicate that the Cbk1 phosphory-
lation sites in Bcr1 are physiologically relevant for Bcr1 function
during biofilm formation.
Cbk1-mediated phosphorylation of Bcr1 is required for
full ALS3 and ALS1 expression
To determine whether Cbk1 phosphorylation sites in Bcr1 were
important to regulate its transcriptional activity, we analyzed the
expression levels of Bcr1-dependent genes in cells containing the
phosphomutant Bcr1 proteins. Figure 4A shows ALS3 and ALS1
transcript levels measured by RT-PCR in the wild-type, bcr1D,
bcr1EE and bcr1AA strains. Both ALS3 and ALS1 expression in
bcr1EE cells was similar to that of the wild-type strain, whereas a
significant reduction was observed in the bcr1AA mutant. Never-
theless, expression was still significantly higher in the bcr1AA mutant
compared to the bcr1D null mutant, in which the transcripts were
dramatically reduced, as previously described [8,9]. The decrease in
the expression of these Bcr1-dependent genes observed in bcr1AA
cells was not due to changes in Bcr1 abundance, since Bcr1 protein
levels were similar in the bcr1AA-HA, bcr1EE-HA and BCR1-HA
strains (Figure 4B). Therefore, these findings suggest that phos-
phorylation of Bcr1 at Cbk1 phospho-acceptor sites is important for
full expression of Bcr1-dependent genes ALS3 and ALS1.
The bcr1EE allele partially complements the cbk1D
biofilm defect in vitro
The hypothesis stated above predicts that the bcr1EE allele
might suppress, at least partially, the biofilm defects observed in a
cbk1D strain. We tested this prediction by integrating the bcr1EE or
bcr1AA alleles in a cbk1D/cbk1D BCR1/bcr1D background. The
adherence ability and biomass production of the double mutants
were tested and compared to those of the parental strain. While
the results obtained with the cbk1D bcr1AA mutant were similar to
those found for the cbk1D reference strain, the introduction of
bcr1EE in the cbk1D background resulted in a significant increase
in the number of adherent cells and biomass (Figure 5A and 5B).
The cbk1D bcr1EE double mutant exhibited adherence values 3-
fold-higher than those of the cbk1D mutant and biofilm biomass
production was doubled, although these values were still lower
than those found in the wild type. CSLM imaging also revealed
qualitative differences between cbk1D bcr1EE and cbk1D strains
(Figure 5C). Whereas the rudimentary biofilms formed by the
cbk1D strain were composed of few groups of round yeast cells, the
cbk1D bcr1EE strain produced a biofilm with higher cell density
that included yeast and pseudohyphal cells. Therefore, the
phosphomimetic bcr1EE mutant partially rescues the biofilm
formation defects of the cbk1D strain.
Given the phenotypic differences between both strains, we next
analyzed whether the introduction of bcr1EE allele had any effect
on Bcr1 transcriptional activity. RT-PCR assays showed that ALS3
and ALS1 expression levels in the cbk1D mutant were dramatically
decreased compared to wild-type levels (Figure 5D). Notably, the
cbk1D bcr1EE double mutant exhibited a significant increase in
ALS3 and ALS1 transcripts versus the cbk1D reference strain (5.3-
fold increase for ALS3 and 3-fold increase for ALS1). Altogether,
these results strongly suggest that the RAM pathway regulates
Bcr1 transcriptional activity and, therefore, biofilm development,
through Cbk1-dependent phosphorylation.
Analysis of Bcr1 phosphomutants in disseminated
murine candidiasis
In addition to its role in biofilm formation, Bcr1 has been shown to
contribute to C. albicans virulence. Indeed, inactivation of BCR1
are the mean of 3 independent experiments counting 30 fields per strain in each one. (D) Biofilms induced on silicon squares for 60 hours were
stained with calcofluor white and concanavaline A for CSLM visualization.
doi:10.1371/journal.ppat.1002683.g001
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results in a fitness defect in a mouse model of disseminated
candidiasis when compared to the wild-type and other C. albicans
knock-out mutant strains [29]. Hence, we tested whether the Cbk1-
dependent phosphorylation of Bcr1 could contribute to its function
in virulence. Immuno-competent BALB-c mice were infected
intravenously with C. albicans BCR1/BCR1, BCR1/bcr1D, bcr1D/
bcr1D, bcr1AA and bcr1EE strains and mortality was recorded over a
14-day period. As shown in Figure 6, inactivation of one copy of
Figure 2. Bcr1 is a phosphoprotein that interacts in vivo with Cbk1. (A) Schematic representation of Cbk1 consensus phosphorylation sites in
Bcr1. Gray rectangles: Zn finger domains. (B) Cell extracts from a BCR1-HA strain (JC1144) grown at 37uC in Spider medium were analyzed by Western
blot using anti-HA antibodies. A fraction from the same lysates was treated with l-phosphatase (lPP). (C) Cell lysates from wild-type (WT, JC1144) and
cbk1D (JC1159) strains grown in Spider medium at 37uC were subjected to 2D-WB and probed with anti-HA antibodies. Half of each lysate was
treated with l-phosphatase. Histograms obtained using ImageJ show the quantification of the relative intensity of each spot of the blot. (D) Protein
extracts from a CBK1-myc BCR1-HA strain (JC1151) were immunoprecipitated using anti-HA antibodies. A strain carrying CBK1-myc (JC305) was used as
negative control of the immunoprecipitation. Samples were separated by SDS-PAGE and probed with anti-myc or anti-HA antibodies.
doi:10.1371/journal.ppat.1002683.g002
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BCR1 did not impair C. albicans virulence while inactivation of the
two BCR1 alleles resulted in significant reduction of C. albicans
virulence (p,0.005), as anticipated from previous observations [29].
Similarly, the bcr1AA mutant showed reduced virulence, suggesting
that Cbk1-mediated phosphorylation of Bcr1 is required for C.
albicans virulence. The most striking result was obtained with the
bcr1EE mutant that showed reduced virulence to a level similar to
that observed with the bcr1D and bcr1AA mutants (Figure 6). These
results suggest that phosphorylation and dephosphorylation of Bcr1
is required for full virulence of C. albicans.
Discussion
Control of gene expression is a conserved function of NDR/
LATS kinases in eukaryotic cells [30,31]. The aim of this work was
to assess whether the NDR/LATS kinase Cbk1 was involved in
transcriptional control during C. albicans biofilm development. A
survey for Cbk1 consensus sites in the C. albicans proteome allowed
the identification of a subset of C2H2 Zn finger transcriptional
regulators of biofilm development as putative Cbk1 targets (Bcr1, 2
sites; Ace2, 3 sites; Nrg1, 3 sites; and Zap1, 3 sites). Since these
proteins are required at different stages of biofilm formation
[25,8,10,26], this observation might suggest that Cbk1 regulates
transcriptional activity at different steps during C. albicans biofilm
development. Here, we have studied the function of Cbk1 at early
stages of biofilm formation, and our findings suggest that full
activation of Bcr1 is dependent on Cbk1 phosphorylation.
Recently, a phenotypic analysis of a collection of protein kinase
mutants identified Cbk1 as a kinase required for biofilm formation
[21]. In agreement with this observation, we have found that
Figure 3. Characterization of the phenotype of BCR1-phosphorylation mutants in biofilm formation in vitro. BCR1 phosphomimetic
(bcr1T191E/bcr1D, JC1094; bcr1S556E/bcr1D, JC1092; bcr1EE/bcr1D, JC1180) and phosphodefective (bcr1T191A/bcr1D, JC1093; bcr1S556A/bcr1D, JC1088;
bcr1AA/bcr1D, JC1178) mutants were grown in biofilm-inducing conditions for 40 hours using microfermentors. BCR1/bcr1D (WT, JC1089) and bcr1D
(JC1081) strains were used as controls. (A) Quantification of adherent cells. (B) Biofilm dry mass determination. (C) Biofilms grown using silicon
squares models were stained with calcofluor white for CSLM visualization.
doi:10.1371/journal.ppat.1002683.g003
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RAM mutants have severe biofilm formation defects similar to that
of the cbk1D strain. The impaired biofilm development of RAM
mutants could be due to their inability to develop hyphae
[32,16,17], since hyphal formation is important for biofilm
development in C. albicans [33]. However, a cph1D efg1D strain
defective in hyphae development is able to produce rudimentary
biofilms and express a set of biofilm-related genes in a
microfermentor model [7]. In contrast to cph1D efg1D cells,
RAM mutants did not produce a compact layer of yeast cells in the
same biofilm-formation model, suggesting a severe defect in cell-
surface adherence. Given the central role of Bcr1 in this process,
we rationalized that Cbk1 phosphorylation could be required for
Bcr1 activation.
The results presented in this report indicate that Cbk1 regulates
Bcr1 function during biofilm development, and this is based on the
following evidences. First, biofilm mass production and adherence
of RAM mutants were similar to that of bcr1D cells. Second, using
2D gels we have shown that the Bcr1 phosphorylation status was
partially Cbk1-dependent. In addition, coimmunoprecipitation
experiments revealed a physical interaction between Cbk1 and
Bcr1. Third, the bcr1AA allele lacking Cbk1 phosphorylation sites
phenocopied bcr1D cells, whereas the bcr1EE allele behaved as the
wild-type, indicating that phosphorylation of the two Cbk1-
consensus sites is essential for Bcr1 function. In addition, the
expression of Bcr1-dependent genes were reduced in bcr1AA cells
as compared to the BCR1/bcr1D strain, suggesting that phosphor-
ylation of Cbk1 sites in Bcr1 is required for full activation of the
transcriptional program required for biofilm formation. In support
of this idea, an upregulation in ALS3 and ALS1 expression was
observed in the bcr1EE cbk1D strain in comparison to the cbk1D
mutant (5.3-fold increase for ALS3 and 3-fold increase for ALS1).
Given that overexpression of these adhesins in a bcr1D background
restores biofilm formation in vitro and in vivo [9,34], the
downregulation of ALS3 and ALS1 observed in bcr1AA cells could
account for their phenotypic defects. Finally, the phosphomimetic
bcr1EE allele partially rescued the biofilm defects of cbk1D cells.
This partial rescue could be taken as an indication that Cbk1 has
additional functions in biofilm development that are independent
of the two Bcr1 phosphorylation sites (T191 and S556). One
possibility could be that Cbk1 also plays a role in regulating the
Ace2 transcription factor. In S. cerevisiae, Cbk1-dependent phos-
phorylation of Ace2 is required for its biological function [20]. In
C. albicans, expression of Ace2 target genes depends on Cbk1 [17]
and we and others have shown that Ace2 is required for adhesion
to surfaces [25]. Alternatively, it is also possible that Cbk1 controls
other regulatory factors required for biofilm development. This is
based on the fact that ALS3 expression levels in bcr1EE cbk1D cells
were still 2.6-fold lower than those of bcr1EE or BCR1/bcr1D cells
(Figure 5D), suggesting that full expression of ALS3 also requires
Cbk1 in a Bcr1-independent manner. One possible scenario could
be that Cbk1 also negatively regulates a repressor of ALS3
expression, such as Nrg1 that contains three Cbk1 consensus sites
(S200, T251 and T281). The transcriptional repressor Nrg1
downregulates ALS3 transcription by binding to two regions in the
ALS3 promoter [35]. Thus, it is possible that full activation of ALS3
expression during biofilm formation would require the inactivation
of the Nrg1 repressor and the activation of the Bcr1 transcription
factor, and that both events could be dependent on the
phosphorylation of their Cbk1-consensus sites.
Another likely target of Cbk1 is the RNA-binding protein Ssd1
which contains multiple Cbk1-phosphorylation sites. In S.
cerevisiae, the absence of Cbk1 in cells expressing functional
Ssd1 severely impairs cell growth [36]. Recently, it has been
shown that Ssd1 associates with specific mRNAs which encode
proteins involved in bud growth and cell wall remodeling [37].
Cbk1-dependent phosphorylation of Ssd1 is required for trans-
lation of these mRNAs whereas Cbk1 inhibition promotes Ssd1
association with P bodies and thereby translational repression of
Ssd1-associated mRNAs [37,38]. Given the growth defect of S.
cerevisiae cbk1D cells is suppressed by deletion of SSD1, a functional
Ssd1 is likely to cause a negative effect on cell growth that is
inactivated by Cbk1. In C. albicans, the same genetic interaction
between CBK1 and SSD1 has been described [16]. Therefore, the
activation of Ssd1 could account for the biofilm defects shown by
the RAM mutants. However, since expression of Bcr1EE is able
to alleviate the biofilm defects of cbk1D cells, it is likely that Cbk1
controls biofilm formation, at least partially, through the
regulation of Bcr1 transcriptional activity. Further work on the
functional interaction between Cbk1 and Ssd1 is an interesting
area to determine the role of translational control during biofilm
formation in C. albicans.
Regulation through phosphorylation is an important mecha-
nism for controlling the activity of transcription factors [39,40].
How Cbk1-dependent phosphorylation of Bcr1 regulates the
transcriptional activity of the protein is unclear. In metazoans
NDR/LATS kinase-dependent phosphorylation of YAP/TAZ co-
activators results in their cytoplasmic retention and subsequent
ubiquitination and degradation [23,24,41,42]. In S. cerevisiae, the
Figure 4. Phosphorylation of Cbk1 consensus sites is required
for Bcr1 transcriptional activity. (A) Expression of the Bcr1 target
genes ALS3 and ALS1 measured by quantitative RT-PCR in the wild-type
(JC1089), bcr1D (JC1081), bcr1EE (JC1180) and bcr1AA (JC1178) strains
normalized using ADE2. The data are the mean of two independent
experiments. (B) Cells from the wild-type BCR1-HA (JC1144), bcr1EE-HA
(JC1177) and bcr1AA-HA (JC1176) strains were grown at 37uC in Spider
medium. Protein extracts were probed with anti-HA antibodies. Anti-
PSTAIRE antibodies were used as loading control.
doi:10.1371/journal.ppat.1002683.g004
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Figure 5. Characterization of the in vitro biofilm formation phenotype of the cbk1D bcr1EE double mutant. (A) Quantification of
adherence ability to plastic slides of wild-type (JC1089), cbk1D BCR1 (JC1082), cbk1D bcr1AA (JC1096) and cbk1D bcr1EE (JC1099) cells. (B) The same
strains were incubated during 40 hours in microfermentors and biofilm dry mass was determined. (C) CSLM images of biofilms induced using silicone
squares after calcofluor white staining. (D) Quantitative RT-PCR measurements of ALS3 and ALS1 transcription levels in the wild-type, cbk1D BCR1 and
cbk1D bcr1EE strains normalized using ADE2.
doi:10.1371/journal.ppat.1002683.g005
Figure 6. Cbk1-dependent phosphorylation of Bcr1 is required for virulence during disseminated candidiasis. Mice were infected
intravenously with 56105 yeast phase cells of the indicated C. albicans strains. The graphs represent the survival over a 14-day period (n = 10 mice per
strain). * P,0.005.
doi:10.1371/journal.ppat.1002683.g006
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NDR/LATS kinase Cbk1 has the opposite functional output,
since it promotes nuclear accumulation of the transcription factor
Ace2 by phosphorylating two sites within its nuclear export
sequence (NES) [20]. In C. albicans, our findings indicate that Cbk1
is not involved in regulating Bcr1 stability. Since Bcr1 does not
contain an obvious NES close to the Cbk1 phosphorylation sites,
we speculate that nuclear-cytoplasmic shuttling may not be a
major output of Cbk1 phosphorylation. Therefore, a possibility is
that the Cbk1-dependent phosphorylation might regulate the
interaction of Bcr1 with other components of the transcription
machinery.
Another significant conclusion of this work is that Cbk1-
dependent regulation of Bcr1 is important for virulence in C.
albicans. As previously described [29], we found that cells lacking
Bcr1 were less virulent in disseminated murine candidiasis.
Supporting a role for Cbk1 in Bcr1 activation, the bcr1AA strain
showed a similar reduced virulence. Strikingly, the phosphomi-
metic bcr1EE mutant also showed the same reduced virulence.
Since C. albicans mutants that are locked in the yeast form are less
virulent in disseminated murine candidiasis [43–45], one possibil-
ity is that the virulence defect of these mutants might be a
consequence of a defect in hyphal formation. However, bcr1D cells
[8] and BCR1 phosphomutants produced wild-type hyphae in
hyphae-inducing conditions (not shown). Therefore, our results
indicate that not only Cbk1-dependent phosphorylation of Bcr1,
but also its dephosphorylation at specific moments of the infection
process, are required for full virulence in in vivo models. Given that
the addition of phosphates to specific residues of proteins can
modify their interaction with other proteins [46,47], a dynamic
Bcr1 phosphorylation state could be required to modify its
interaction with other regulatory factors required for Bcr1-
dependent gene expression. This could aid in the colonization of
different niches in response to environmental cues within the host.
In C. albicans, developmentally regulated genes appear to be
controlled by complex interactions between several transcription
factors at their promoters [35,48]. The ALS3 gene is a good
example of such complexity, since its expression is regulated by
multiple transcription factors, including Efg1, Cph1, Bcr1, Nrg1,
Rfg1 and Tup1 [35]. However, we could not exclude that the
virulence defects observed in phosphomimetic bcr1 mutants were
due to conformational changes that might reduce its function
during infection.
In sum, our results indicate that the RAM signaling pathway
plays an important role in regulating Bcr1 function through its
phosphorylation at two specific residues mediated by the Cbk1
kinase and that this phosphorylation is required for proper biofilm
formation and virulence. Interestingly, the two phosphorylation
sites are also conserved in other species, such as Candida dubliniensis
or Candida tropicalis. In the Candida parapsilosis Bcr1 ortholog, which
is also required for biofilm formation [49], the putative Cbk1
phosphorylation site at the end of the first Zn finger domain
(T214) is also present. Therefore, the role of the RAM pathway in
the control of Bcr1 function might be conserved in other biofilm-
forming species.
Table 1. Strains used in this study.
Name Genotype Source
CEC369 ura3D::limm434/ura3D::limm434 arg4D::hisG/ARG4 his1D::hisG/HIS1 RPS1/rps1::CIp10-URA3 [55]
JC305 CBK1-myc::HIS1/CBK1 [17]
JC343 ace2::ARG4/ace2::URA3 CBK1-MYC-HIS1/CBK1 This study
JC525 mob2::ARG4/mob2::URA3 CBK1-YFP-HIS1/CBK1 This study
JC798 kic1::ARG4/kic1::HIS1 MOB2-HA-URA3/MOB2 This study
JC848 tao3::ARG4/tao3::HIS1 MOB2-HA-URA3/MOB2 This study
JC1080 cbk1::ARG4/cbk1::HIS1 RPS10/rps10::CIp10-URA3 This study
JC1081 bcr1::URA3/bcr1::ARG4 his1D/HIS1 This study
JC1082 bcr1::BCR1-URA3/bcr1::SAT1 cbk1::ARG4/cbk1::HIS1 This study
JC1088 bcr1-S556A-URA3/bcr1::ARG4 his1D/HIS1 This study
JC1089 bcr1::BCR1-URA3/bcr1::ARG4 his1D/HIS1 This study
JC1092 bcr1-S556E -URA3/bcr1:: ARG4 his1D/HIS1 This study
JC1093 bcr1-T191A-URA3/bcr1::ARG4 his1D/HIS1 This study
JC1094 bcr1-T191E-URA3/bcr1::ARG4 his1D/HIS1 This study
JC1096 bcr1-T191A/S556A-URA3/bcr1::SAT1 cbk1::ARG4/cbk1::HIS1 This study
JC1099 bcr1-T191E/S556E-URA3/bcr1::SAT1 cbk1::ARG4/cbk1::HIS1 This study
JC1144 BCR1-HA::URA3/bcr1::ARG4 his1D/HIS1 This study
JC1151 BCR1-HA::URA3/bcr1::ARG4 CBK1-myc::HIS1/CBK1 This study
JC1159 BCR1-HA::URA3/BCR1 cbk1::ARG4/cbk1::HIS1 This study
JC1176 bcr1-T191A/S556A-HA::SAT1-URA3/bcr1::ARG4 his1D/HIS1 This study
JC1177 bcr1-T191E/S556E-HA::SAT1-URA3/bcr1::ARG4 his1D/HIS1 This study
JC1178 bcr1-T191A/S556A-URA3/bcr1::ARG4 his1D/HIS1 This study
JC1180 bcr1-T191E/S556E-URA3/bcr1::ARG4 his1D/HIS1 This study
All the strains referred in this work derive from BWP17.
doi:10.1371/journal.ppat.1002683.t001
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Materials and Methods
Ethics statement
All animal experiments adhered to the EU Directive 86/609 on
the approximation of laws, regulations and administrative
provisions of Member States regarding the protection of animals
used for experimental and other scientific purposes, and to related
national regulations. All experiments were performed according to
the guidelines of the European Convention for the Protection of
Vertebrate Animals Used for Experimental and Other Scientific
Purposes (ETS No. 123). The protocol was approved by Institut
Pasteur Health Center Animal Care Committee (Protocol
number: 10.455). Recovery of organs was performed following
euthanasia of animals, and all efforts were made to minimize
suffering.
Media
C. albicans strains were grown in YPD (2% Bacto Peptone, 2%
dextrose, 1% yeast extract) for transformation experiments.
Transformants were selected on synthetic medium (2% dextrose,
6.7% YNB and auxotrophic supplements) or YPD supplemented
with clonNAT at a final concentration of 200 mg ml21 (Werner
BioAgents) for Nat+ strains. For adherence and biofilm formation
assays using microfermentors, overnight cultures were grown in
synthetic medium with 0.4% dextrose supplemented with arginine,
histidine and uridine (20 mg ml21) and then diluted in the same
medium supplemented with methionin (200 mg ml21). For the
biofilm formation on silicone squares, cells were grown in synthetic
medium with 0.9% dextrose and supplemented with arginine,
histidine, uridine and methionin at the concentrations mentioned
above.
Plasmid and strain construction
The strains used in this study are listed in Table 1 and derived
from the BWP17 strain [50]. Disruption and epitope-tagged
strains were made according to the PCR-mediated system using
pFA plasmids [51,52]. Strains were confirmed by PCR. Oligonu-
cleotides were obtained from Biomers.net (Ulm, Germany) and are
listed in Table 2. For site directed mutagenesis, fragments carrying
bcr1 T191A/E or S556A/E modifications were generated by PCR
from genomic DNA of the JC1084 strain. The PCR products were
inserted into pSC-A vector (Strataclone PCR cloning kit) for
sequencing and then digested with both EcoRV and ClaI for the
T191 fragment or BstBI for the S556 fragment, giving rise to a
DNA fragment of 798 bp or 666 bp, respectively. These fragments
were used to swap the wild-type BCR1 regions of a pGEM-URA3-
based vector, that contained the complete wild type BCR1 ORF
fragment cloned into the SacI site and a 39UTR–BCR1 region
inserted into the NotI site (+194 to +704 from the stop codon) to
direct integration of the plasmid to the BCR1 locus. The
constructions were digested with SalI and AflII and transformed
into a BCR1 heterozygous strain using a standard lithium acetate
method [53]. The transformants were confirmed by PCR and
sequencing. Strains used for biofilm formation assays were
transformed to uracil and histidine prototrophy using StuI-
linearized CIp10 [54] or SacI/SacII-digested ECC72 plasmids
respectively. ECC72 contains 2.9 kb from the HIS1 locus (from
1000 bp upstream of the start codon to 1000 bp downstream of
the stop codon) which were PCR amplified and cloned in the
pGEM-T (Promega) EcoRV site.
Adherence
Surface adherence was determined incubating plastic slides
(Thermanox, Nunc) with OD600 = 1 cell cultures during 1 hour at
room temperature and washing three times with PBS to remove
non-adherent cells. Cells attached to the plastic surface were
recovered by vortexing and resuspended in 15 ml of PBS, using
5 ml for counting the adherent cells with an optical microscope.
For each strain the average of cells/field is the result of counting a
total of 30 fields from three independent experiments.
Biofilm formation
Microfermentor assays were done as described previously [7]
while the method of the silicone squares used for microscopy
analysis was described in [12]. For dry mass measurements, after
the incubation period in the microfermentor, the plastic slides
were removed from the glass spatula and transferred to a 50 ml
tube with 10 ml of water. Cells were detached from the plastic
surface by vortexing and then recovered by filtration using
Millipore 1.2 mm filters. Filters were dried during 48 hours at
60uC prior mass measurement. Total biomass of each biofilm
sample was calculated by subtracting the mass of a blank filter
subjected to the same washing and drying treatment. For each
strain the experiment was repeated twice in duplicate.
Microscopy and image analysis
Biofilm development in microfermentors was recorded with a
Nikon Coolpix digital camera. For the silicone square experi-
ments, biofilms were observed by CSLM, after staining with
calcofluor white 0.01% (vol/vol) and 10 mg ml21 concanavaline A
Alexa fluor 594 conjugate (Invitrogen) for 1 h in the dark at 37uC
with 150 rpm agitation. CSLM was performed with an upright
Zeiss Axioskop2 FS MOT LSM 510 multiphoton microscope
using a Zeiss Achroplan640/0.8 W objective. All CSLM stacks
were assembled into projections using the Image J software.
Protein extracts, Western Blotting, 2D-WB and
immunoprecipitation
Cells extracts, Western blotting, 2D-WB and immunoprecipi-
tation assays were done as previously described [17].
RNA isolation and expression analysis
Cultures for RNA extraction were done as previously described
[9]. For RNA extraction mid-logarithmic cell cultures were
harvested, frozen in liquid nitrogen and stored at 280uC. 50 mg
of cells were lysed in a FastPrep cell disruptor in the presence of
50 ml TRIzol Reagent (Invitrogen). Total RNA was isolated
according to manufacturer’s instructions. The quantity, quality
and integrity of the RNA were analyzed in an Agilent’s 2100
Bioanalyzer system. cDNA synthesis was performed with the
SuperScript II First-Strand Synthesys System (Invitrogen) using
oligo(dT), from 3 mg total RNA previously treated with DNAase I
(Invitrogen). qPCR assays were done using SYBR Premix Ex Taq
(TaKaRa). For each reaction, 1 ml cDNA was used. No-template
and no-reverse transcription controls were included. The assays
were carried out in duplicates at generic cycle conditions (95uC for
45 s and 40 cycles of 95uC for 5 s and 60uC for 31 s, followed by a
dissociation step at 95uC for 15 s, 60uC for 1 min and 95uC for
15 s) in an Applied Biosystems 7300 Real-Time PCR System
(Applied Biosystems). Relative gene expression quantification was
achieved using the Pfaff1 method.
Disseminated murine candidiasis assays
Nine week-old female Balb c/J mice were infected intravenously
with 56105 CFU/mouse. Ten mice per strain were tested per
experiment and mice were kept in groups of 5 per cage. 2 days
after infection 2 mice/strain were sacrificed, the kidneys taken,
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Table 2. Primers used in this study.
Deletion and gene disruption
Name Sequence 59-39
S1BCR1 GAATCATTCATTCATTCTAATTGTTGGGATATTTTATTTTATCAAGTTTTTATAATAATACAAATCTATCAATATTATTT AATAATAACTTAAATTTTCATTG-
AAGCTTCGTACGCTGCAGGTC
S2BCR1 AACAAATAGTATATATGTAAATCAAGTAGAACACTCATACTCAGTTTATATAACAAACGAGTAAAGTAAGAACACTATAA AAAAGAAACAACATCAAAAA-
TCTGATATCATCGATGAATTCGAG
Tagging
Name Sequence 59-39
S1BCR1HA AACAACAACAAATACAAATACAAATACAAATAGTACGGCTACTACTAATGCTACTGGGTATGTTTCGAAAAAACCTACGATAAATAATTTAATATCACA-
AACGCGTTATCCATATGATGTTCC
S2BCR1HA AACAAATAGTATATATGTAAATCAAGTAGAACACTCATACTCAGTTTATATAACAAACGAGTAAAGTAAGAACACTATAAAAAAGAAACAACATCAAAAA-
CCAGGGTTTTCCCAGTCACGACG
S1CBK1myc TGCTAAGAATGGAGGCGGCAGAAAGAATCCAAAGGAAGATTTACCATTTATTGGATACACTTATTCTAGATTTGATTATTTGACA AGAAAGAATGCG
TTACGGATCCCCGGGTTAATTAA
S2CBK1myc ATAATGCATAAACAATAACATCATCCGGCTGTACTACCATTCCAAATGACCACCTATTGTTGATACATGTATGATAAGAAAAGGT TGGCATG-
CTTTGTTGGAATTCCGGAATATTTATGAGAA
Bcr1 site-directed mutagenesis
Name Sequence 59-39
M1-BCR1-SacI AGCTCGAGCTCATCATGTCAGGGACATCACAAGTACTTC
M2-BCR1-SphI AGCTCGCATGCATCAAGTAGAACACTCATACTCAGT
M1B-BCR1 TCTAATGAAAATATTAGTAATGAAGGG
M2B-BCR1 CTAGGTGGTGGTGGATAAACTGCAT
M3A BCR1 CTCGTCATAAACGTAAACATGCGGGTGAACGACCTTTTACTTG
M3E BCR1 CTCGTCATAAACGTAAACATGAGGGTGAACGACCTTTTACTTG
M4A BCR1 CAAGTAAAAGGTCGTTCACCCGCATGTTTACGTTTATGACGAG
M4E BCR1 CAAGTAAAAGGTCGTTCACCCTCATGTTTACGTTTATGACGAG
M5A BCR1 CTTTTCATCAACGTCAAAGTGCGGTTGTTAGTGATTTTCTGAT
M5E BCR1 CTTTTCATCAACGTCAAAGTGAGGTTGTTAGTGATTTTCTGAT
M6A BCR1 ATCAGAAAATCACTAACAACCGCACTTTGACGTTGATGAAAAG
M6E BCR1 ATCAGAAAATCACTAACAACCTCACTTTGACGTTGATGAAAAG
39UTR-BCR1-59 AGCTCTCTAGAGGGGTGACGACAGTGTTTAATTTAAT
39UTR-BCR1-39 AGCTCGCGGCCGCATTGAAATTCAACAATCTCCCTTCCCA
Sequencing
BCR1-1S CACAGCACGCATCTATGGCTTATAA
BCR1-2S CACTAACGCCGACATTAACCAATGCTAC
BCR1-3S GCTTATGAAACTTATTTAACTAAGGATAATCG
BCR1-4S AGGTTATTTGGATCCATATAGACAA
BCR1-5S CCACCACCACCTAGATCAGCAACTT
BCR1-6S GAGCAACAACAACAACAACTACAAG
BCR1-7S CGGCTACTACTAATGCTACTGGGTA
Integration
Name Sequence 59-39
G1BCR1 CCCCATATTACATATCATATCTTTA
G2BCR1 CCGCCCCCCCTTACACGACACACCG
G1CBK1myc ACAAACCATGCAAACATGGAG
G1CBK1 CACTTCAAAGCAATTTGAGAATACGCCTCC
G2CBK1 GGTCATTCAAGGGTGAGCAAG
MYC2 CACCGTCGAGTCCGTTCAAGTC
X2CaARG4 AATGGATCAGTGGCACCGGTG
X3CaARG4 GCTCTTGGTGGTACTGCTAAAAGTGCCG
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homogenized and plated on SD medium containing 50 mg/ml
ticarcillin and 10 mg/ml gentamycin. The fungal burden was
determined by counting CFUs after 2 days at 30uC. Mice were
checked 2 times per day for survival over a period of 14 days. At
day 14 all remaining mice were sacrificed. Results were analyzed
using the software GraphPad Prism5.
Acknowledgments
We are grateful to Marie-Elisabeth Bougnoux and Zacarias Garcia for help
with animal experiments. We thank Javier Encinar and Oscar Zaragoza for
critical comments of the manuscript. Imaging was performed at the PFID
station (Institut Pasteur, Paris).
Author Contributions
Conceived and designed the experiments: PGE MBS SBB CdE JCB.
Performed the experiments: PGE UZ MBS ACB JB. Analyzed the data:
PGE UZ MBS SBB CRVdA CdE JCB. Contributed reagents/materials/
analysis tools: CRVdA CdE JCB. Wrote the paper: PGE CRVdA CdE
JCB.
References
1. Kumamoto CA (2002) Candida biofilms. Curr Opin Microbiol 5: 608–611.
2. Douglas LJ (2003) Candida biofilms and their role in infection. Trends
Microbiol 11: 30–36.
3. Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of
infectious biofilms. Trends Microbiol 13: 34–40.
4. Kojic EM, Darouiche RO (2004) Candida infections of medical devices. Clin
Microbiol Rev 17: 255–267.
5. Verstrepen KJ, Reynolds TB, Fink GR (2004) Origins of variation in the fungal
cell surface. Nat Rev Microbiol 2: 533–540.
6. Finkel JS, Mitchell AP (2011) Genetic control of Candida albicans biofilm
development. Nat Rev Microbiol 9: 109–118.
7. Garcı´a-Sa´nchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, et al. (2004) Candida
albicans biofilms: a developmental state associated with specific and stable gene
expression patterns. Eukaryot Cell 3: 536–545.
8. Nobile CJ, Mitchell AP (2005) Regulation of cell-surface genes and biofilm
formation by the C. albicans transcription factor Bcr1p. Curr Biol 15: 1150–1155.
9. Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, et al. (2006) Critical role of
Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo.
PLoS Pathog 2: e63.
10. Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, et al. (2009)
Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol 7: e1000133.
11. Ganguly S, Bishop AC, Xu W, Ghosh S, Nickerson KW, et al. (2011) Zap1
control of cell-cell signaling in Candida albicans biofilms. Eukaryot Cell 10:
1448–1454.
12. Nobile CJ, Nett JE, Andes DR, Mitchell AP (2006) Function of Candida albicans
adhesin Hwp1 in biofilm formation. Eukaryot Cell 5: 1604–1610.
13. Racki WJ, Becam AM, Nasr F, Herbert CJ (2000) Cbk1p, a protein similar to
the human myotonic dystrophy kinase, is essential for normal morphogenesis in
Saccharomyces cerevisiae. EMBO J 19: 4524–4532.
14. Bidlingmaier S, Weiss EL, Seidel C, Drubin DG, Snyder M (2001) The Cbk1p
pathway is important for polarized cell growth and cell separation in
Saccharomyces cerevisiae. Mol Cell Biol 21: 2449–2462.
15. Weiss EL, Kurischko C, Zhang C, Shokat K, Drubin DG, et al. (2002) The
Saccharomyces cerevisiae Mob2p-Cbk1p kinase complex promotes polarized growth
and acts with the mitotic exit network to facilitate daughter cell-specific
localization of Ace2p transcription factor. J Cell Biol 158: 885–900.
16. Song Y, Cheon SA, Lee KE, Lee SY, Lee BK, et al. (2008) Role of the RAM
network in cell polarity and hyphal morphogenesis in Candida albicans. Mol Biol
Cell 19: 5456–5477.
17. Gutie´rrez-Escribano P, Gonza´lez-Novo A, Sua´rez MB, Li C-R, Wang Y, et al.
(2011) Cdk-dependent phosphorylation of Mob2 is essential for hyphal
development in Candida albicans. Mol Biol Cell 22: 2458–2469.
18. Jansen JM, Barry MF, Yoo CK, Weiss EL (2006) Phosphoregulation of Cbk1 is
critical for RAM network control of transcription and morphogenesis. J Cell Biol
175: 755–766.
19. Colman-Lerner A, Chin TE, Brent R (2001) Yeast Cbk1 and Mob2 activate
daughter-specific genetic programs to induce asymmetric cell fates. Cell 107:
739–750.
20. Mazanka E, Alexander J, Yeh BJ, Charoenpong P, Lowery DM, et al. (2008)
The NDR/LATS family kinase Cbk1 directly controls transcriptional
asymmetry. PLoS Biol 6: e203.
21. Blankenship JR, Fanning S, Hamaker JJ, Mitchell AP (2010) An extensive
circuitry for cell wall regulation in Candida albicans. PLoS Pathog 6: e1000752.
22. Dong J, Feldmann G, Huang J, Wu S, Zhang N, et al. (2007) Elucidation of a
universal size-control mechanism in Drosophila and mammals. Cell 130:
1120–1133.
23. Zhao B, Wei X, Li W, Udan RS, Yang Q, et al. (2007) Inactivation of YAP
oncoprotein by the Hippo pathway is involved in cell contact inhibition and
tissue growth control. Genes Dev 21: 2747–2761.
24. Hao Y, Chun A, Cheung K, Rashidi B, Yang X (2008) Tumor suppressor
LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283: 5496–5509.
25. Kelly MT, MacCallum DM, Clancy SD, Odds FC, Brown AJ, et al. (2004) The
Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence.
Mol Microbiol 53: 969–983.
Table 2. Cont.
Integration
Name Sequence 59-39
X2CaHIS1 CAACGAAATGGCCTCCCCTACCACAG
X3CaHIS1 GACGAATTGAAGAAAGCTGGTGCAACCG
X2CaURA3 GTGTTACGAATCAATGGCACTACAGC
X3CaURA3 GGAGTTGGATTAGATGATAAAGGTGATGG
X2SAT1 GCACACACTACTTAATATACACAG
X3SAT1 GTGAAGTGTAAGGGGGAG
Quantitative RT-PCR
Name Sequence 59-39
ADE2 forward TGTTGTCACATCTTCCATGC
ADE2 reverse ATTCCCACCAATGGAGATTC
ALS1 forward AGCTTGACAACAGGCACCTC
ALS1 reverse TCATTTGAAGCACTGGCAAC
ALS3 forward CGTCCTCATTACACCAACCA
ALS3 reverse ACAACCTTTATCACCTTCACAGC
doi:10.1371/journal.ppat.1002683.t002
Bcr1 Regulation in Fungal Biofilm Formation
PLoS Pathogens | www.plospathogens.org 12 May 2012 | Volume 8 | Issue 5 | e1002683
26. Uppuluri P, Pierce CG, Thomas DP, Bubeck SS, Saville SP, et al. (2010) The
transcriptional regulator Nrg1p controls Candida albicans biofilm formation and
dispersion. Eukaryot Cell 9: 1531–1537.
27. Ganguly S, Mitchell AP (2011) Mucosal biofilms of Candida albicans. Curr Opin
Microbiol 14: 380–385.
28. Baladro´n V, Ufano S, Duen˜as E, Martı´n-Cuadrado AB, del Rey F, et al. (2002)
Eng1p, an endo-1,3-beta-glucanase localized at the daughter side of the septum,
is involved in cell separation in Saccharomyces cerevisiae. Eukaryot Cell 1: 774–786.
29. Noble SM, French S, Kohn LA, Chen V, Johnson AD (2010) Systematic screens
of a Candida albicans homozygous deletion library decouple morphogenetic
switching and pathogenicity. Nat Genet 42: 590–598.
30. Hergovich A, Stegert MR, Schmitz D, Hemmings BA (2006) NDR kinases
regulate essential cell processes from yeast to humans. Nat Rev Mol Cell Biol 7:
253–264.
31. Maerz S, Seiler S (2010) Tales of RAM and MOR: NDR kinase signaling in
fungal morphogenesis. Curr Opin Microbiol 13: 663–671.
32. McNemar MD, Fonzi WA (2002) Conserved serine/threonine kinase encoded
by CBK1 regulates expression of several hypha-associated transcripts and genes
encoding cell wall proteins in Candida albicans. J Bacteriol 184: 2058–2061.
33. Ramage G, VandeWalle K, Lopez-Ribot JL, Wickes BL (2002) The
filamentation pathway controlled by the Efg1 regulator protein is required for
normal biofilm formation and development in Candida albicans. FEMS Microbiol
Lett 214: 95–100.
34. Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, et al. (2008)
Complementary adhesin function in C. albicans biofilm formation. Curr Biol 18:
1017–1024.
35. Argimon S, Wishart JA, Leng R, Macaskill S, Mavor A, et al. (2007)
Developmental regulation of an adhesin gene during cellular morphogenesis in
the fungal pathogen Candida albicans. Eukaryot Cell 6: 682–692.
36. Kurischko C, Weiss G, Ottey M, Luca FC (2005) A role for the Saccharomyces
cerevisiae regulation of Ace2 and polarized morphogenesis signaling network in
cell integrity. Genetics 171: 443–455.
37. Jansen JM, Wanless AG, Seidel CW, Weiss EL (2009) Cbk1 regulation of the
RNA-binding protein Ssd1 integrates cell fate with translational control. Curr
Biol 19: 2114–2120.
38. Kurischko C, Kim HK, Kuravi VK, Pratzka J, Luca FC (2011) The yeast Cbk1
kinase regulates mRNA localization via the mRNA-binding protein Ssd1. J Cell
Biol 192: 583–598.
39. Karin M, Hunter T (1995) Transcriptional control by protein phosphorylation:
signal transmission from the cell surface to the nucleus. Curr Biol 5: 747–757.
40. Montminy M (1997) Transcriptional activation. Something new to hang your
HAT on. Nature 387: 654–655.
41. Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, et al. (2010) The hippo tumor
pathway promotes TAZ degradation by phosphorylating a phosphodegron and
recruiting the SCF{beta}-TrCP E3 ligase. J Biol Chem 285: 37159–37169.
42. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL (2010) A coordinated
phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-
TRCP). Genes Dev 24: 72–85.
43. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, et al. (1997)
Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939–949.
44. Phan QT, Belanger PH, Filler SG (2000) Role of hyphal formation in
interactions of Candida albicans with endothelial cells. Infect Immun 68:
3485–3490.
45. Park H, Myers CL, Sheppard DC, Phan QT, Sanchez AA, et al. (2005) Role of
the fungal Ras-protein kinase A pathway in governing epithelial cell interactions
during oropharyngeal candidiasis. Cell Microbiol 7: 499–510.
46. Serber Z, Ferrell JE, Jr. (2007) Tuning bulk electrostatics to regulate protein
function. Cell 128: 441–444.
47. Strickfaden SC, Winters MJ, Ben-Ari G, Lamson RE, Tyers M, et al. (2007) A
mechanism for cell-cycle regulation of MAP kinase signaling in a yeast
differentiation pathway. Cell 128: 519–531.
48. Kim S, Wolyniak MJ, Staab JF, Sundstrom P (2007) A 368-base-pair cis-acting
HWP1 promoter region, HCR, of Candida albicans confers hypha-specific gene
regulation and binds architectural transcription factors Nhp6 and Gcf1p.
Eukaryot Cell 6: 693–709.
49. Ding C, Butler G (2007) Development of a gene knockout system in Candida
parapsilosis reveals a conserved role for BCR1 in biofilm formation. Eukaryot Cell
6: 1310–1319.
50. Wilson RB, Davis D, Mitchell AP (1999) Rapid hypothesis testing with Candida
albicans through gene disruption with short homology regions. J Bacteriol 181:
1868–1874.
51. Gola S, Martin R, Walther A, Dunkler A, Wendland J (2003) New modules for
PCR-based gene targeting in Candida albicans: rapid and efficient gene targeting
using 100 bp of flanking homology region. Yeast 20: 1339–1347.
52. Schaub Y, Dunkler A, Walther A, Wendland J (2006) New pFA-cassettes for
PCR-based gene manipulation in Candida albicans. J Basic Microbiol 46:
416–429.
53. Walther A, Wendland J (2003) An improved transformation protocol for the
human fungal pathogen Candida albicans. Curr Genet 42: 339–343.
54. Murad AM, Lee PR, Broadbent ID, Barelle CJ, Brown AJ (2000) CIp10, an
efficient and convenient integrating vector for Candida albicans. Yeast 16:
325–327.
55. Firon A, Aubert S, Iraqui I, Guadagnini S, Goyard S, et al. (2007) The SUN41
and SUN42 genes are essential for cell separation in Candida albicans. Mol
Microbiol 66: 1256–1275.
Bcr1 Regulation in Fungal Biofilm Formation
PLoS Pathogens | www.plospathogens.org 13 May 2012 | Volume 8 | Issue 5 | e1002683
